Yamin Khan, chief executive at Open Orphan, joined Katie to talk about Hvivo, a subsidiary of Open Orphan, signing a multi-million pound influenza human challenge study contract.
The contract is with a German-based biotech company.
Open Orphan PLC on its subsidiary's new study contract
